Argentina vs Republic of Moldova: Reported cases of paralytic polio by world region
Argentina
0 cases
in 2023
Republic of Moldova
0 cases
in 2023
Argentina rank
26th
Republic of Moldova rank
26th
Reported cases of paralytic polio by world region over time
- Argentina
- Republic of Moldova
How they compare
Argentina currently reports 0 cases against 0 cases in Republic of Moldova, a difference of 0 cases.
Across all 33 years both countries report, Republic of Moldova has been ahead every year.
Argentina ranks 26th and Republic of Moldova ranks 26th of 199 countries.
Republic of Moldova has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Argentina | Republic of Moldova | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 cases | 0.6667 cases | 0.6667 cases | Republic of Moldova |
| 2000s | 0 cases | 0 cases | 0 cases | — |
| 2010s | 0 cases | 0 cases | 0 cases | — |
| 2020s | 0 cases | 0 cases | 0 cases | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported cases of paralytic polio by world region, Argentina or Republic of Moldova?
- Argentina, at 0 cases against 0 cases in Republic of Moldova as of 2023.
- What is the difference in reported cases of paralytic polio by world region between Argentina and Republic of Moldova?
- 0 cases, with Argentina ahead.
- How many years of comparable data are there for Argentina and Republic of Moldova?
- 33 years are reported by both, from 1991 to 2023.
- How do Argentina and Republic of Moldova rank globally for reported cases of paralytic polio by world region?
- Argentina ranks 26th and Republic of Moldova ranks 26th of 199 countries.
- Where does this data come from?
- World Health Organization (2019); World Health Organization (2024) – processed by Our World in Data, published as Reported cases of paralytic polio by world region. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Sum of wild poliovirus cases and circulating vaccine derived poliovirus cases.